Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma
暂无分享,去创建一个
M. Veening | J. Loeffen | A. Beishuizen | V. Peperzak | M. Hagleitner | F. Meyer-Wentrup | P. Greve | M. Boes | Claudius Diez